United States · FDA National Drug Code directory
Ondansetron Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-3178_f74fee7b-ae98-4fbb-84fb-23cd573e3936
- Product NDC
- 50090-3178
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ondansetron Hydrochloride
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070731
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET, FILM COATED in 1 BOTTLE (50090-3178-0) · 50090-3178-0
- 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-3178-1) · 50090-3178-1
- 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-3178-2) · 50090-3178-2
- 3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-3178-4) · 50090-3178-4
- 12 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-3178-5) · 50090-3178-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →